Scholarlink

Background <p>Trisomy 21, also known as Down syndrome (DS), is the most common chromosomal cause of intellectual disability. While ~ 95% of cases are due to standard trisomy 21 from meiotic nondisjunction, a minority involve structural rearrangements, such as isochromosome 21q [i(21q)]. Differentiating i(21q) from Robertsonian translocations is essential for recurrence risk assessment, as the latter often arise from parental balanced rearrangements. Molecular techniques like quantitative fluorescence PCR (QF-PCR) and STR analysis can support conventional cytogenetics in clarifying the nature and origin of structural variants.</p> Case presentation <p>A 36-year-old primigravida was referred for genetic counseling at 14&#xa0;weeks due to high first-trimester screening risk for trisomy 21. Ultrasound showed increased nuchal translucency but no structural anomalies. QF-PCR on amniotic fluid indicated trisomy 21, and karyotyping revealed a 46,XY,i(21)(q10) constitution. STR analysis confirmed a homologous duplication of chromosome 21q of paternal origin. No mosaicism was detected in parental blood, supporting a de novo event, though germline mosaicism could not be excluded. The pregnancy was terminated at 19&#xa0;weeks.</p> Discussion <p>This case underscores the importance of combined cytogenetic and molecular analyses for accurate diagnosis of DS due to structural anomalies. While cytogenetically similar to Robertsonian translocations, i(21q) shows full homozygosity for chromosome 21 markers and carries a distinct recurrence risk profile.</p> Conclusions <p>An integrated diagnostic strategy can facilitate accurate fetal aneuploidy characterization and ensure accurate risk estimation for future pregnancies, which is especially relevant when distinguishing isochromosome 21q from Robertsonian translocations, thereby improving genetic counseling for affected families.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Prenatal diagnosis of chromosome 21q homologous rearrangement: integrated cytogenetic and molecular characterization

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年10月17日

查看全文
  • Miriam Lucia Carriero,
  • Ludovico Graziani,
  • Silvia Di Tommaso,
  • Cristiana Di Rosa,
  • Liliana Mannucci,
  • Valentina Brugiati,
  • Antonio Novelli,
  • Leila Baghernajad Salehi,
  • Anna Maria Nardone,
  • Giuseppe Novelli

摘要

Background

Trisomy 21, also known as Down syndrome (DS), is the most common chromosomal cause of intellectual disability. While ~ 95% of cases are due to standard trisomy 21 from meiotic nondisjunction, a minority involve structural rearrangements, such as isochromosome 21q [i(21q)]. Differentiating i(21q) from Robertsonian translocations is essential for recurrence risk assessment, as the latter often arise from parental balanced rearrangements. Molecular techniques like quantitative fluorescence PCR (QF-PCR) and STR analysis can support conventional cytogenetics in clarifying the nature and origin of structural variants.

Case presentation

A 36-year-old primigravida was referred for genetic counseling at 14 weeks due to high first-trimester screening risk for trisomy 21. Ultrasound showed increased nuchal translucency but no structural anomalies. QF-PCR on amniotic fluid indicated trisomy 21, and karyotyping revealed a 46,XY,i(21)(q10) constitution. STR analysis confirmed a homologous duplication of chromosome 21q of paternal origin. No mosaicism was detected in parental blood, supporting a de novo event, though germline mosaicism could not be excluded. The pregnancy was terminated at 19 weeks.

Discussion

This case underscores the importance of combined cytogenetic and molecular analyses for accurate diagnosis of DS due to structural anomalies. While cytogenetically similar to Robertsonian translocations, i(21q) shows full homozygosity for chromosome 21 markers and carries a distinct recurrence risk profile.

Conclusions

An integrated diagnostic strategy can facilitate accurate fetal aneuploidy characterization and ensure accurate risk estimation for future pregnancies, which is especially relevant when distinguishing isochromosome 21q from Robertsonian translocations, thereby improving genetic counseling for affected families.